Glycemic effects of simvastatin: Where do we stand?
ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2018-06-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100403&lng=en&tlng=en |